Literature DB >> 27639128

Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma.

Rolf W Sparidans1, Hilde Rosing2, Johannes J M Rood3, Jan H M Schellens4, Jos H Beijnen5.   

Abstract

Entities:  

Keywords:  Afatinib; Encorafenib; Erlotinib; Gefitinib; LC–MS/MS; Plasma

Mesh：

Substances：

Year:  2016        PMID： 27639128     DOI： 10.1016/j.jchromb.2016.09.012

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN： 1570-0232            Impact factor:   3.205


× No keyword cloud information.
  5 in total

1.  Quantitative determination of erlotinib in human serum using competitive enzyme-linked immunosorbent assay.

Authors:  Yuta Yamamoto; Tetsuya Saita; Yutaro Yamamoto; Masashi Shin
Journal:  J Pharm Anal       Date:  2018-02-08

2.  Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib.

Authors:  Rintaro Sogawa; Tetsuya Saita; Yuta Yamamoto; Sakiko Kimura; Yutaka Narisawa; Shinya Kimura; Masashi Shin
Journal:  J Pharm Anal       Date:  2018-09-18

3.  Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer.

Authors:  Kazumi Sano; Kazuhiko Nakadate; Kazuhiko Hanada
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

4.  A Validated LC-MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation.

Authors:  Mohamed W Attwa; Hany W Darwish; Nasser S Al-Shakliah; Adnan A Kadi
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

Review 5.  FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management.

Authors:  Isabelle Solassol; Frédéric Pinguet; Xavier Quantin
Journal:  Biomolecules       Date:  2019-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.